Times have been rather interesting for shareholders in Rite Aid (RAD), one of the big three publicly-traded pharmacy retailers in the US. Despite the fact that the firm is expected to be acquired by Walgreens Boots Alliance (WBA), following an acceptance by management in October of 2015 of an offer to be bought up, shares of Rite Aid have tanked and are trading well below the purchase price they should be acquired at. With the deadline for the acquisition nearing and after seeing shares of the business soar 12% on June 19th before scaling back a bit in the two days following that, I figured that it would be interesting to dig in and see what kind of potential, if any, the company might offer long-term investors.

READ FULL ARTICLE HERE